CBBT - Cerebain Biotech Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0000 (0.00%)
At close: 3:37PM EDT
Stock chart is not supported by your current browser
Previous Close0.0011
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0009 - 0.0011
52 Week Range0.0005 - 0.1400
Avg. Volume27,049,519
Market Cap154,245
Beta (3Y Monthly)7.21
PE Ratio (TTM)N/A
EPS (TTM)-0.0650
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire

    Cerebain Initiates Repositioning and Review of Business and Corporate Strategic Growth Plan

    Cerebain Biotech Corp. (CBBT), (the “Company” or “Cerebain”) today announced that it has initiated a repositioning and review of its overall business and corporate strategic plan to maximize shareholder value. The corporate strategic initiatives to be developed and implemented include, but are not limited to, a potential sale or divestiture of certain Company assets, rebranding and repositioning of the Company’s overall business plan and a comprehensive growth strategy focused on revenue generation through a comprehensive roll-up acquisition strategy of target qualified candidates in select industries. To assist and advise on the development and implementation of the Company’s overall plan, it has engaged NMS Consulting, Inc., (“NMS Consulting”) an independent, global focused management consulting, corporate strategy and strategic communications firm.

  • We're sorry this is all we were able to find about this topic.